Drug Database
Back to search

Belgium· BE-AMP-SAM000996-00

Imap 2 mg/ml

A fluspirilene product containing fluspirilene, registered in Belgium by Eumedica Pharmaceuticals. The same ATC class is registered in 4 of our 19 countries.

ATC N05AG01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedImap 2 mg/mlATCN05AG01REGISTER NO.BE-AMP-SAM000996-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fluspirileneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fluspirilene is registered in 4 of 19 countries.

Countries holding a registration under ATC N05AG01 (fluspirilene), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 1 of them publish a price we can compare per daily dose
Search fluspirilene products by name

Fluspirilene · ATC N05AG01

4 / 19 countries

  • Belgiumprice
  • Germany
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Fluspirilene
Manufacturer
Eumedica Pharmaceuticals
Country
Belgium (BE)
ATC code
N05AG01
ATC class
Fluspirilene
Defined daily dose
0.7 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0050005
  • be_apb
    0709055

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluspirilene in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluspirilene products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Imap
  • Luxembourg · Imap
  • Netherlands · Imap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3b845870-47c3-4c84-855a-be07b23379bc
GET /v1/drugs/3b845870-47c3-4c84-855a-be07b23379bc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Imap 2 mg/ml",
  "name_fr": "Imap 2 mg/ml",
  "name_nl": "Imap 2 mg/ml",
  "amp_code": "SAM000996-00",
  "strengths": [
    "12.0000",
    "72.0000",
    "52.2000",
    "15.0000",
    "60.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Fluspirilene",
    "Benzyl Alcohol",
    "Disodium Hydrogen Phosphate",
    "Sodium Dihydrogen Phosphate Monohydrate",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fluspirilene",
  "authorisation_numbers": [
    "BE000996"
  ]
}
API referenceMCP serverPlans

See everything about fluspirilene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console